Rea, Milagros A.
HRN: 28-34-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFTRIAXONE 1G (VIAL)
12/27/2025
01/03/2026
IV
2g
OD
CAP MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines